Application 214755

Type
NDA
Sponsor
AVADEL CNS PHARMA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LUMRYZSODIUM OXYBATESUSPENSION;ORAL4.5GNoNo
002LUMRYZSODIUM OXYBATESUSPENSION;ORAL6GNoNo
003LUMRYZSODIUM OXYBATESUSPENSION;ORAL7.5GNoNo
004LUMRYZSODIUM OXYBATESUSPENSION;ORAL9GNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84209SUPPL 2025-11-19
81540SUPPL 2025-03-12
80657SUPPL 2024-12-20
80488SUPPL 2024-12-04
79944SUPPL 2024-10-21
79943SUPPL 2024-10-21
79910SUPPL 2024-10-17
79756SUPPL 2024-09-27
79751SUPPL 2024-09-26
77203SUPPL 2024-01-11
74154ORIG 2023-11-07
76031SUPPL 2023-11-02
76005ORIG 2023-10-31
74150ORIG 2023-05-02
71622ORIG2022-07-25